| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384874C Protein a chromatography |
| 04/29/2008 | US7364859 Methods of using bioelastomers |
| 04/29/2008 | US7364741 Peptides of human Papilloma virus for use in human T cell response inducing compositions |
| 04/29/2008 | CA2337667C Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 04/23/2008 | EP1659919A4 Hemostatic devices containing a protein precipitate |
| 04/23/2008 | EP1182458B1 Method for detecting proteins under mutual interaction |
| 04/23/2008 | CN101166761A Peptide synthesizing method |
| 04/23/2008 | CN100383158C Method and compositions for peptide synthesis |
| 04/22/2008 | US7361731 Lithography; ink jet printing; for drug delivery |
| 04/22/2008 | US7361640 Stable lipid-comprising drug delivery complexes and methods for their production |
| 04/22/2008 | US7361369 Implant with structure allowing injection of polymer for attaching implant to tissue |
| 04/22/2008 | US7361352 Influenza immunogen and vaccine |
| 04/22/2008 | US7361349 Immunocastration of pigs |
| 04/22/2008 | US7361337 Antibodies against the PRO1754 polypeptides |
| 04/17/2008 | WO2008044957A1 Proteom differential analysis method |
| 04/17/2008 | WO2008044692A1 Protein suitable for protein orientation control/immobilization and immobilization support for the protein |
| 04/17/2008 | CA2664517A1 Ph sensitive liposome composition |
| 04/16/2008 | EP1910533A2 Static support bed for purification, separation, detection, modification and/or immobilization of target entities and method using thereof |
| 04/16/2008 | EP0885244B2 Peptide immunogens for vaccination against and treatment of allergy |
| 04/16/2008 | CN101163718A Reagents that bind ccx-ckr2 |
| 04/16/2008 | CN100381420C N-acetyl cysteine derivatives and use thereof |
| 04/15/2008 | US7358339 PRO polypeptide without the N-terminal signal sequence and/or the initiating methionine is encoded by a nucleotide sequence |
| 04/15/2008 | US7358096 Immobilisation of proteins |
| 04/15/2008 | US7357941 implanting matrix for bioactive material which is biocompatible porous forms of beta -tricalcium phosphate granules support the development of new bone throughout its structural form, together with bone morphogenic protein as bioactive material |
| 04/10/2008 | WO2008041767A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor |
| 04/10/2008 | WO2008040536A1 Method for peptide synthesis |
| 04/10/2008 | WO2008017483A3 Spore surface displays of bioactive molecules |
| 04/10/2008 | US20080085837 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation |
| 04/10/2008 | CA2665559A1 Method for peptide synthesis |
| 04/10/2008 | CA2664356A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor |
| 04/09/2008 | EP1908828A1 Novel polypeptide and method for producing the same |
| 04/09/2008 | EP1692514A4 Binding assay components |
| 04/09/2008 | EP1664123B1 Large scale preparation of alpha-1 proteinase inhibitor and use thereof |
| 04/09/2008 | CN101160524A Compositions and methods for classifying biological samples |
| 04/09/2008 | CN101160133A Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| 04/09/2008 | CN100379761C Titanium dioxide complex having molecule distinguishability |
| 04/09/2008 | CN100379760C Peptides and compounds that bind to receptor |
| 04/08/2008 | US7355018 human insulin-like growth factor-1 fusion polypeptide that includes a component capable of forming a multimer with another modified IGF-1 fusion polypeptide; useful for treating a muscle-related disease or condition, such as muscle atrophy |
| 04/08/2008 | US7355013 PRO6017 antibodies |
| 04/08/2008 | US7355007 Antibodies that bind PRO5005 Polypeptides |
| 04/08/2008 | US7355006 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/08/2008 | US7354998 PRO7171 polypeptides |
| 04/08/2008 | US7354995 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for producing the complex structure |
| 04/08/2008 | US7354991 Heptapeptides having the natural binding site for autoantibodies found in elevated levels in schizophrenics binds to serum sample obtained from a schizophrenic patient at a substantively higher level than its binding to a body fluid sample obtained from a non-schizophrenic individual; diagnosis kits |
| 04/08/2008 | US7354896 Suspension containing milk fat spheres; therapy for infant weight diseases |
| 04/08/2008 | US7354589 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations |
| 04/03/2008 | WO2007051605A3 Methods for determining the cleavability of substrates |
| 04/02/2008 | CN101156068A Method for detecting misfolded proteins and prions |
| 04/02/2008 | CN101155824A Peptide synthesis of alpha-helixes on peg resin |
| 04/02/2008 | CN101152574A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/02/2008 | CN101152573A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/01/2008 | US7351804 Antibodies against PRO4421 |
| 04/01/2008 | US7351803 CD16A binding proteins and use for the treatment of immune disorders |
| 04/01/2008 | US7351801 Using cation exchange on a bimodal high salt tolerant matrix to isolate/recover human serum albumin from cell culture supernatant |
| 04/01/2008 | US7351798 Stabilized protein crystals, formulations comprising them and methods of making them |
| 04/01/2008 | US7351794 PRO1754 polypeptides |
| 04/01/2008 | US7351793 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 04/01/2008 | US7351789 For pharmaceuticals, diagnostics, biosensors and bioreactors |
| 04/01/2008 | CA2195289C Detectable polymers and methods for detecting polymers in aqueous systems |
| 03/27/2008 | WO2008034575A1 Iminosugar glycoconjugates |
| 03/27/2008 | WO2003075845A3 Immunogenicity of glucan binding protein |
| 03/27/2008 | US20080076904 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/27/2008 | DE102006042012A1 Verfahren zur Unterstützung von Immuntherapien Practices in support of immunotherapies |
| 03/26/2008 | EP1902313A1 Trityl derivatives for enhancing mass spectrometry |
| 03/26/2008 | EP1901761A2 Thrombospondin-1 derived peptides and treatment methods |
| 03/26/2008 | EP1033953B1 Method of cross-linking keratin-based films, sheets, and bulk materials |
| 03/25/2008 | US7348415 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferation disorders |
| 03/25/2008 | US7348414 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 03/25/2008 | US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins |
| 03/25/2008 | US7348404 Solid-phase peptide synthesis and agent for use in such synthesis |
| 03/25/2008 | US7348403 Contacting a peptide with the agent under conditions permitting formation of a phosphorus-based ester; and determining whether a phosphorus-based ester has formed between the peptide and the agent; inactivation of organophosphorus-based insecticides and chemical warfare agents |
| 03/25/2008 | US7348399 Nanofabricated polypeptide multilayer films, coatings, and microcapsules |
| 03/25/2008 | US7348155 Method for identifying compounds for treating aging processes in the coronary circulatory system |
| 03/25/2008 | US7348009 Recombinant allergen with reduced enzymatic activity |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/19/2008 | EP1901069A1 Fret protease assays for clostridial toxins |
| 03/19/2008 | EP1899434A1 Fluorescent polymers soluble in an aqueous solution and a method for the production thereof |
| 03/19/2008 | EP1899381A1 Immobilisation of polypeptides by irradiation |
| 03/19/2008 | EP1899363A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 03/19/2008 | EP1009831B1 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 03/19/2008 | CN101143888A Preparation method for immune nano magnetic glucan micro-sphere |
| 03/18/2008 | US7345148 Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides |
| 03/18/2008 | US7345147 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 03/18/2008 | US7345146 PRO1271 Polypeptides |
| 03/13/2008 | WO2008030253A2 Multilayer films, coatings and microcapsules comprising polypeptides |
| 03/13/2008 | WO2008028206A2 Method for producing reactive monolayer units |
| 03/13/2008 | CA2632703A1 Multilayer films, coatings and microcapsules comprising polypeptides |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896605A2 Stimulation of pancreatic b cell proliferation |
| 03/12/2008 | EP1896065A2 Process for manufacturing vaccines |
| 03/12/2008 | EP1896047A1 Anti-gfralpha3 antibodies |
| 03/12/2008 | EP1682866A4 Gel-shell beads with adsorbed or bound biomolecules |
| 03/12/2008 | CN100374477C Nano granules adhesive to mucous membrane, preparation method and application |
| 03/11/2008 | US7342109 Used in diagnosis; small cell lung cancer, lung adenocarcinoma, T-cell lymophoblastic lymphoma, glioblastoma, gastric carcinoma, colon adenocarcinoma, prostate carcinoma, pancreatic carcinoma, esophagus epidermoid carcinoma and promonocytic leukemia |
| 03/11/2008 | US7342096 PRO1879 polypeptide |
| 03/11/2008 | US7342093 nhibitor of Apoptosis (IAP) proteins, cancer |
| 03/11/2008 | US7342092 Vaccines as dosage forms; acute myeloblastic leukemia |